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It has long been appreciated that the microtubule network plays a critical role in endothelial cell
function. Chemical inhibition of tubulin polymerization has been shown to drastically increases endo-
thelial permeability via interactions with the actin cytoskeleton. Conversely, stabilization of microtubules
signiﬁcantly decreases vascular permeability. The purpose of this investigation was to determine if the
low molecular weight fraction of commercial 5% human serum albumin (LMWF5A) alters endothelial cell
cytoskeletal dynamics and function. To investigate this, human retinal endothelial cells (HREC) were
treated with LMWF5A and the acetylation of a-tubulin was determined by immunoﬂuorescent staining
and immunoblotting. In addition, permeability assays were performed to evaluate functional changes.
We found that HREC treated with LMWF5A exhibit a rapid increase in the amount and distribution of
acetylated a-tubulin. This was accompanied by a reduction in macromolecular permeability. Calcium
depletion and inhibition of PI3-kinase reduced LMWF5A-induced acetylation while p38 MAPK inhibition
potentiated this effect. These ﬁndings suggest that LMWF5A mediates changes in the microtubule
network and reduces transcytosis in HREC.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Microtubules (MT) are ﬁlamentous cytoskeletal proteins that
play a role in a number of essential cellular processes including
division, migration, and intracellular transport [1]. To execute this
diverse set of functions, MT continuously explore the cytoplasmaction of 5% albumin; HREC,







Inc. This is an open access article uthrough a process termed dynamic instability [2]. Typically, MT are
polymers composed of a and b tubulin heterodimers arranged in an
array of 13 head-to-tail protoﬁlaments, aligned in parallel, to form
hollow cylindrical tubes [3]. This conﬁguration affords MT the
ability to exist at variable lengths with GTP hydrolysis providing the
trigger for stochastic phases of growth and collapse [2]. In order to
polymerize, each tubulin heterodimer constitutively associates
with a GTP molecule at each protein, with b-tubulin serving as a
GTPase. As long as GTP-bound tubulin is added more rapidly than
hydrolysis, a GTP-cap exists that stabilizes themolecule and growth
continues. If the rate slows, however, the cap is lost and the poly-
mer will rapidly depolymerize.
Due to these inherent chemical complexities, a host of
conserved post translational modiﬁcations have evolved that help
dictate function [4,5]. These decorations, in turn, regulate distinct
interactions with a variety of microtubule-associated proteinsnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Unique among these modiﬁcations is the reversible acetylation of
a-tubulin at lysine-40 in that it resides on the luminal side, not on
the outward surface or near the c-terminal tail [5]. On the basis of
this observation it was believed that this modiﬁcationwas simply a
gauge of the age or stability of the polymer but recent reports hint
at more far-reaching and dynamic implications. Knock-out studies
in mice have demonstrated that ﬁbroblasts lacking aTat1/MEC-17,
the major a-tubulin acetyltransferase, exhibit reduced contact in-
hibition and cell adhesion [6]. Moreover, activation of HDAC6, a
known tubulin deacetylase, by extracellular signal-related kinase
has been shown to promote cellular migration [7]. These ﬁndings
indicate that the functional consequences of tubulin acetylation are
more encompassing then originally suspected.
It has long been appreciated that the MT are fundamental to
endothelial cell function. For example, incubation of endothelial
cells with paclitaxel, a microtubule stabilizing compound, signiﬁ-
cantly reduces permeability [8]. Conversely, destabilization of mi-
crotubules with nocodazole and vinblastine increases permeability
through myosin light chain phosphorylation and Rho-GTPase
activation [9]. Interestingly, the disruption of microtubules with
2-methoxyestradiol is attenuated by treatment with the p38 in-
hibitor, SB203580 [10]. As a whole, these ﬁndings indicate that an
intimate relationship exists, across all components of the cyto-
skeleton, to regulate permeability. Also of note, a hallmark of the
aforementioned investigations is an overall change in a-tubulin
acetylation status.
The purpose of this investigationwas to explore the effect of the
low molecular weight fraction of commercial 5% albumin
(LMWF5A) on endothelial cytoskeletal dynamics and function.
LMWF5A is a biologic derived from the less than 5 kDa fraction of
human serum albumin currently under development as a thera-
peutic for osteoarthritis of the knee. In clinical trials, a single intra-
articular injection of LMWF5A resulted in a signiﬁcant 42.3%
reduction in pain, which was observed 4 weeks following injection
and persisted to the completion of the trial, versus saline controls
[11]. In vitro experiments have also demonstrated that LMWF5A
possess anti-inﬂammatory properties by inhibiting cytokine
release from both stimulated peripheral blood mononuclear cells
(PBMC) and T-cell lines [12e14]. Recent studies show that LMWF5A
potentiates the release of an anti-inﬂammatory prostaglandin,
(15d-PGJ2) from LPS-stimulated PBMC [14,15]. Furthermore,
LMWF5A treatment of bone marrow-derived mesenchymal stem
cells (BMMSC) reduced Rho GTPase activity and stress ﬁber for-
mation [16]. Based on these observations, we hypothesized that
LMWF5A reduces vascular permeability. To test this, we investi-
gated in vitro permeability and monitored cytoskeletal changes by
both cell imaging and immunoblotting. Our ﬁndings suggest that
LMWF5A mediates changes to the microtubule network and re-
duces macromolecular permeability. These observations expand
our knowledge of the mechanisms of LMWF5A and suggest that
this biologic may alter microtubule dynamics and transcytosis.2. Materials and methods
2.1. Reagents
All reagents were purchased from Sigma Aldrich (St. Louis, MO)
unless otherwise stated. SB203580 was obtained from Thermo-
Fisher Scientiﬁc (Waltham, MA). The 5 kDa ﬁltrate of commercial
5% HSA was isolated by Ampio Pharmaceuticals (Englewood, CO)
using tangential ﬂow ﬁltration (TFF) and a 5 kDa MWCO Hydrosart
ﬁlter membrane (Sartorius Stedim Biotech GmbH, Germany).2.2. Primary retinal endothelial cells
Primary human retinal endothelial cells (HREC) purchased from
Cell Systems (Kirkland, WA) were cultured in EGM-2 growth me-
dium supplemented as recommended (Lonza, Walkersville, MD)
and used at passage 6 to 9.
2.3. Endothelial permeability assays
HRECwere grown to conﬂuence in 0.1 mmpore transwell inserts
(Thincerts; Greiner, Monroe NC) coated with 10 mg/cm2 ﬁbronectin.
Medium containing either saline, forskolin in saline (10 mM ﬁnal
concentration), or LMWF5A mixed equally with EGM-2 medium
was then added. To measure macromolecular permeability,
strepavidin-horseradish peroxidase (HRP; ThermoFisher Scientiﬁc)
was added to the upper chambers at a ﬁnal concentration of 42 ng/
ml. Colorimetric analysis was evaluated after 24 h by drawing 10 ml
from the bottom chamber and mixing with 100 ml tetrame-
thylbenzidine substrate solution (ThermoFisher Scientiﬁc). After
5min, the reactions were stoppedwith 100 ml 0.18MH2SO4 and the
absorbance was measured at 450 nm (Spectra Max M2e microplate
reader; Molecular Devices, Sunnyvale, CA). Resistive changes were
measured by growing HREC to conﬂuence on ﬁbronectin-coated,
8W10E þ electrode arrays attached to an ECIS Ztheta system
(Applied Biophysics, Troy NY) in EGM-2 medium. Solutions were
then replaced with either saline or LMWF5A mixed equally with
EGM-2, and impedance was monitored at 4000 Hz for 48 h, with
data presented as normalized resistance.
2.4. Immunoﬂuorescence staining
HREC were grown on glass bottom 24-well tissue culture plates
(Cellvis, Mountain View, CA) coated with 2% gelatin in EGM-2.
Medium was then exchanged with a combination of 500 ml saline,
working dilutions of compounds to be tested prepared in saline
(ﬁnal concentrations of 10 mM LY294002, 10 mM SB203580, 2 mM
EGTA, 100 mM UTP, and 0.2 mM Thapsigargin), or LMWF5A together
with 500 ml EGM-2 and incubated for the indicated times.
Following treatment, cells were ﬁxed using 10% neutral buffered
formalin for 10 min and permeabilized with 0.1% Triton X-100 in
PBS for 5 min 4% goat serum (ThermoFisher Scientiﬁc) prepared in
PBS was used to block the cells for 1 h then anti-acetylated a-
tubulin clone 6-11B-1 antibody (1:1000; Santa Cruz Biotechnology,
Santa Cruz, CA) was added in blocking solution overnight at 4 C.
Alexa Fluor 488-conjugated anti-mouse IgG (1:1000; Invitrogen,
Carlsbad, CA) was then added for 1 h followed by DAPI counter
staining (300 nM in PBS; ThermoFisher Scientiﬁc) for 5 min.
Randomly selected frames were photographed on an inverted mi-
croscope (Zyla sCMOS camera; Andor, South Windsor, CT and
eclipse Ti; Nikon, Melville, NY) and ﬂuorescence intensity was
measured using ImageJ software (http://imagej.nih.gov/ij) [17]. For
normalization, the number of DAPI-stained nuclei was determined
for each frame, and data are presented as median FU/DAPI objects.
2.5. Immunoblot analysis
HREC were grown to conﬂuence on 2% gelatin coated 6-well
culture dishes then treated as described for immunoﬂuorescent
staining with volumes scaled accordingly. Following treatment,
cells were lysed in 100 ml lysis buffer (Qproteome Mammalian
Protein kit; Qiagen, Valencia, CA) according to manufacturer's in-
structions and cleared by centrifugation at 12,000  g for 10 min at
4 C. The lysates were separated by SDS-PAGE after boiling in Bolt
Reducing Buffer and Bolt LDS Sample Buffer (ThermoFisher Scien-
tiﬁc). Western blot analysis was performed using a mouse anti-
Fig. 1. LMWF5A induces acetylation of a-tubulin in HREC. (A) Immunoﬂuorescence
staining for acetylated a-tubulin in HREC treated with Saline or LMWF5A for 3 h. (B)
Quantiﬁcation of a representative immunoﬂuorescence experiment. HREC were
treated for 0.5, 3, 6, or 24 h and stained for acetylated a-tubulin. Data presented as
mean FU normalized to the number of cells determined by DAPI counter staining ± SD
(One-way ANOVA followed by Bonferroni's post hoc, * ¼ p < 0.01 versus Saline,
** ¼ p < 0.02 versus 3 h LWWF5A, n ¼ 6). (C) Representative western blot performed
for acetylated a-tubulin on lysates from HREC treated with LMWF5A for 0.5, 3, 6, or
24 h. Densitometry was then performed and normalized to actin loading.
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mix (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA) followed by
a chicken Alexa Fluor 594-conjugated anti-mouse IgG and chicken
Alexa Fluor 488-conjugated anti-goat IgG antibody mix (1:1000;
Invitrogen, Carlsbad, CA). Immunoblots were visualized on a Kodak
Image station (Carestream Health, Rochester, NY) with appropriate
ﬁlter sets.
2.6. Data analysis
One-way ANOVA tests were performed with post hoc Bonfer-
roni correction, and 95% conﬁdence intervals were constructed
using Excel with signiﬁcance set at 0.05 (Microsoft; Redmond,WA).
3. Results
3.1. LMWF5A induces temporal and phenotypic changes in HREC a-
tubulin acetylation
Previous studies demonstrated that LMWF5A treatment of
BMMSC results in a reduction of cytoplasmic stress-ﬁbers concur-
rent with the development of ﬁlopodia-like projections around the
periphery of the cell [16]. In HREC, however, no appreciable change
in f-actin was observed following treatment (data not shown).
Instead, immunoﬂuorescence (IF) staining revealed that 3 h after
exposure to LMWF5A, HREC exhibited a marked increase in a-
tubulin acetylation, a perceivedmarker of microtubule stabilization
(Fig. 1A). Fig. 1B depicts a representative IF experiment in which
temporal changes in LMWF5A-induced tubulin acetylation were
tracked. A signiﬁcant increase (p < 0.01; n ¼ 6) over the saline
control was observed at all time points tested: 1.5-fold at 30 min,
1.8-fold at 3 h, 1.7-fold at 6 h, and 1.3-fold at 24 h. These ﬁndings
were conﬁrmed by western blot analysis (Fig. 1C). In addition, this
technique afforded the sensitivity to detect increased acetylation,
manifesting after 10 min.
IF also showed that LMWF5A altered the distribution of acety-
lated tubulin in HREC (Supplementary Fig. 1). When viewed at
higher magniﬁcation, acetylated a-tubulin in saline controls was
primarily located in microtubule-organizing centers around the
nucleus. In contrast, LMWF5A-treated HREC exhibited elevated
cytoplasmic and perinuclear staining.
3.2. LY294002 reduces while SB203580 potentiates LMWF5A-
induced acetylation of a-tubulin
Both gene-annotation enrichment and protein kinase array
analysis of BMMSC indicated that treatment with LMWF5A acti-
vates PI3kinase/AKT pathways [16]. Moreover, evidence suggests
that disassembly of microtubules by p38 MAPK contributes to
endothelial cell permeability [8,10]. Therefore, we hypothesized
that these pathways may be involved in the ability of LMWF5A to
acetylate tubulin. For conﬁrmation, HREC were treated with
LMWF5A in the presence of speciﬁc inhibitors for both PI3-kinase
and p38 MAPK and IF was performed after 3 h. As seen in Fig. 2A,
inhibition of PI3-kinase with 10 mM LY294002 reduced LMWF5A-
induced acetylation (p < 0.025 vs LMWF5A þ DMSO; n ¼ 6).
When percent inhibitions were calculated for four separate ex-
periments performed in triplicate, it was found that LY294002
reduced LMWF5A-induced acetylation by 24% (95% CI 29-19).
Conversely, inhibition of p38 MAPK with SB203580 dramatically
increased a-tubulin acetylation versus both saline-DMSO controls
(p < 0.01; n ¼ 6) and LMWF5A-DMSO-treated cells (p < 0.025;
n ¼ 6) by 57% (95% CI 63-51) and 222% (95% CI 236-208) respec-
tively. A similar pattern emerged when analyzed by western blot
after a 3-h incubation (Fig. 2B).3.3. Calcium and LMWF5A-induced acetylation of a-tubulin
In vitro polymerization assays using isolated a-tubulin demon-
strate that calcium triggers disassembly of the polymer [18]. Taken
together with the fact that PI3-kinase can activate second mes-
sengers that release calcium from internal stores, we sought to
explore how calcium affects LMWF5A-induced a-tubulin acetyla-
tion. Fig. 3A provides a representative IF experiment inwhich HREC
were exposed to LMWF5A in the presence of EGTA, uridine-
5'triphosphate (UTP), or thapsigargin. Chelation of extracellular
calcium with 2 mM EGTA reduced both the level of acetylated a-
tubulin in saline controls (p < 0.007; n ¼ 3) as well as attenuated
LMWF5A-induced increases (p < 0.02; n ¼ 3, Fig. 3A). Inhibition of
sarco/endoplasmic reticulum calcium ATPase with thapsigargin,
which causes calcium store depletion, also reduced LMWF5A-
induced acetylation (p < 0.02; n ¼ 3, Fig. 3A). In saline-treated
controls, thapsigargin trended toward a signiﬁcant reduction but
did not survive post hoc correction. On the other hand, 100 mMUTP,
an agonist of purinergic receptors that induces the release of cal-
cium from intracellular stores, increased the detectable amount of
a-tubulin acetylation following treatment with LMWF5A (Fig. 3A).
Combined percent changes calculated for four separate experi-
ments performed in triplicate showed that EGTA and thapsigargin
reduced LMWF5A-induced a-tubulin acetylation by 100% (95% CI
138-62) and 49% (95% CI 56-43) respectively while UTP increased
Fig. 2. Inhibition of PI3-kinase reduces while inhibition of p38 MAPK potentiates
LMWF5A induced acetylation of a-tubulin. (A) Representative immunoﬂuorescence of
HREC exposed to LMWF5A for 3 h in the presence of speciﬁc inhibitors to PI3-kinase
(10 mM LY294002) or p38 MAPK (10 mM SB203580). Data presented as mean FU
normalized to number of cells determined by DAPI counter staining ± SD (One-way
ANOVA followed by Bonferroni's post hoc, * ¼ p < 0.01 versus Saline þ DMSO,
** ¼ p < 0.025 versus LWWF5A þ DMSO, n ¼ 6). (B) Representative western blot
ofacetylated a-tubulin in lysates from HREC treated with LMWF5A for 3 h in the
presence of speciﬁc inhibitors. Densitometry was normalized to actin loading.
Fig. 3. Calcium dependence of LMWF-induced acetylation of a-tubulin. (A) Repre-
sentative immunoﬂuorescence of HREC exposed to LMWF5A for 3 h in the presence
2 mM EGTA, 100 mM UTP, or 0.2 mM Thapsigargin. Data presented as mean FU
normalized to number of cells determined by DAPI counter staining ± SD (One-way
ANOVA followed by Bonferroni's post hoc, * ¼ p < 0.0007 versus Saline, ** ¼ p < 0.02
versus LWWF5A þ Saline, n ¼ 3). (B) Representative western blot performed for
acetylated a-tubulin in lysates from HREC treated with LMWF5A for 3 h in the pres-
ence of EGTA, UTP, or Thapsigargin. Densitometry was normalized to actin loading.
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under these condition were also subjected to immunoblot analysis.
Once again, when corrected for loading, EGTA and thapsigargin
reduced and UTP enhanced acetylation of a-tubulin by LMWF5A
(Fig. 3B). These ﬁndings reﬂect the importance of calcium and
suggest that Ca2þ released from internal stores drives acetylation of
a-tubulin following LMWF5A treatment.3.4. Effect of LWMF5A on retinal endothelial cell permeability
To investigate the functional implications of LMWF5A treat-
ment, in vitro permeability assays were employed. In the ﬁrst,
passage of HRP was determined across conﬂuent monolayers of
HREC established on porous transwell inserts. As seen in Fig. 4A,
LMWF5A signiﬁcantly reduced HRP permeability in this model by
48% as compared to saline-treated controls (p < 0.025; n ¼ 3). A
similar reduction was achieved by treatment with 10 mM forskolin.
Having established that LMWF5A decreases macromolecular
permeability, trans-endothelial electrical resistance was then
monitored for 48 h following treatment. In this assay, an immediate
increase in resistance was observed after exposure to LMWF5A,
lasting 30 min, with a subsequent reduction of 2e5% for approxi-
mately 15 h as compared to saline (Fig. 4B). After 24 h, however,
LMWF5A-treated cells exhibited an increase in resistance that
persisted to completion of the experiment. Taken together, these
data suggest that LMWF5A treatment initially reduces transcytosis,then of offers protection against the breakdown of barrier function
that corresponds with medium exhaustion.
4. Discussion
In the present investigation, we provide evidence that treat-
ment of HREC with LMWF5A induces a rapid, calcium-dependent
acetylation of a-tubulin. Mechanistically, it appears that
LMWF5A-induced acetylation of a-tubulin could be inversely gov-
erned by PI3-kinase and p38 MAPK. In our model, pharmacologic
inhibition of PI3-kinase reduced, while p38 inhibition synergisti-
cally enhanced acetylation following treatment. Compelling evi-
dence supports the observation that these pathways work in
opposing fashion to control microtubule dynamics. On one hand,
PI3-kinase stabilization of microtubules at the leading edge of ﬁ-
broblasts is essential to migration [19]. In the other, p38 inhibition
counters TNFa-induced microtubule disruption in pulmonary ar-
tery endothelial cells [8]. Interestingly, PI3-kinase inhibition in-
creases sensitivity of tumor cells to microtubule depolymerization
with vincristine [20]. This also seems to apply to other cellular
functions since blockade of PI3-kinase promotes VEGF-induced
activation and apoptosis in endothelial cells [21]. Furthermore,
PI3-kinase protects against ventilator-induced vascular perme-
ability inmousemodels by inhibiting p38MAPK signaling [22]. As a
result, we speculate that LMWF5A treatment of HREC leads to
direct inhibition of Lys-40 speciﬁc deacetylases and/or down-
regulation of p38 MAPK through PI3-kinase-mediated cascades.
Our data also suggests that LMWF5A-induced acetylation of a-
Fig. 4. LMWF5A reduces macromolecular permeability and late phase barrier
disruption in HREC. (A) HREC were grown to conﬂuence on transwell inserts then
treated with Saline, LMWF5A, or 10 mM Forskolin. Macromolecular permeability over
24 h was measured by HRP, and relative permeability calculated versus saline controls.
Data presented as Mean ± SD (One-way ANOVA followed by Bonferroni's post hoc,
* ¼ p < 0.025, n ¼ 3) (B) HREC were grown to conﬂuence on electrode arrays. Then
trans-endothelial resistance was monitored for 48 h following treatment with Saline or
LMWF5A.
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depletion, either externally by EGTA or from internal stores with
thapsigargin, reduced acetylation. Moreover, activation of puri-
nergic P2Y receptors using UTP provided an additive effect.
Together, this implies that release of calcium from internal stores
contributes to LMWF5A activity. New insight into the golgi appa-
ratus and mitochondria may place this in biological context. It is
now appreciated that the golgi stores calcium and serves as a non-
centrosomal microtubule-organizing center [23,24]. Additionally,
trafﬁcking of mitochondria is regulated by kinesin-1 via the Ca2þ-
binding protein, Miro [25]. Thus, localized calcium release may
provide the means to rapidly nucleate and acetylate microtubules
to power kinesin-driven motility. Does this explain the increased
cytoplasmic acetylation of a-tubulin observed in LMWF5A treated
HREC? Interestingly, a similar effect was observed by Lee et al. in
which sodium-induced calcium inﬂux increased tubulin acetyla-
tion by downregulating HDAC6 in medulloblastoma DAOY cells
[26].
One of the primary functions of microtubules is to provide the
scaffolding necessary for intracellular trafﬁcking. Dynein andkinesin molecular motors track along these dynamic polymers as
they explore the cytoplasm to deliver cargo [27]. It has also been
well documented that the acetylation of tubulin controls both
kinesin afﬁnity and the directionality of transport [5,28]. Further-
more, transcytosis is a prominent mechanism for the transcellular
passage of macromolecules across endothelial cells [29], thus, we
propose that LMWF5A-induced microtubule acetylation reduces
endocytosis and basolateral transcytosis by enhancing kinesin
binding and activity. In support of this theory, we observed a slight
decrease in resistance across HREC monolayers following treat-
ment with LMWF5A. While counterintuitive, it has been demon-
strated that inhibition of transcytosis in endothelial cells by
blocking dynamin is accompanied by an increase in paracellular
permeability [30]. Taken together with the fact that siRNA knock-
down of dynein reduces the transendothelial transport of albumin
[31], it seems likely that increased plus end trafﬁcking, toward the
periphery of the cell, contributes to LMWF5A activity.
In conclusion, we provide evidence that LMWF5A may reduce
endothelial transcytosis by a microtubule mediated mechanism.
Although further work is warranted to fully elucidate the pathways
involved, our ﬁndings suggest that changes intracellular trafﬁcking
patterns could contribute to both the clinical and in vitro activities
of LMWF5A.
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